Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Antoni Ramos-Quiroga

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
CNS Drugs|December 7, 2010
Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorderJ Antoni Ramos-Quiroga, Miguel Casas
Journal of the American Academy of Child and Adolescent Psychiatry|January 30, 2013
Toward a better understanding of attention-deficit/hyperactivity disorder across the lifespanJ Antoni Ramos-Quiroga, Raquel Vidal, Miguel Casas
Pharmacoepidemiology and Drug Safety|April 8, 2014
Response to Cunill et alJ Antoni Ramos-Quiroga, Pedro Lopez-Romero, Chris Bushe
Expert Review of Neurotherapeutics|September 8, 2010
Impulsivity: current and future trends in pharmacological treatmentMaría Dolores Braquehais, J Antoni Ramos-Quiroga, Leo Sher
The Journal of Sexual Medicine|January 28, 2021
The Impact of Psychosis on Sexual Functioning: A Systematic ReviewSebastián Vargas-Cáceres, Nicoletta Cera, Pedro Nobre, et al.
Expert Review of Neurotherapeutics|August 14, 2009
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorderJ Antoni Ramos-Quiroga, Margarida Corominas, Xavier Castells, et al.
European Child & Adolescent Psychiatry|February 15, 2018
Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHDMichael Huss, Bryan Dirks, Joan Gu, et al.
BMC Psychiatry|October 15, 2015
Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in EuropeWalter Deberdt, Johannes Thome, Jeremie Lebrec, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 14, 2017
Time and psychostimulants: Opposing long-term structural effects in the adult ADHD brain. A longitudinal MR studyClara Pretus, J Antoni Ramos-Quiroga, Vanessa Richarte, et al.
Biological Psychiatry|January 22, 2008
A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorderRossella Medori, J Antoni Ramos-Quiroga, Miguel Casas, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
CNS Drugs|December 7, 2010
Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorderJ Antoni Ramos-Quiroga, Miguel Casas
Journal of the American Academy of Child and Adolescent Psychiatry|January 30, 2013
Toward a better understanding of attention-deficit/hyperactivity disorder across the lifespanJ Antoni Ramos-Quiroga, Raquel Vidal, Miguel Casas
Pharmacoepidemiology and Drug Safety|April 8, 2014
Response to Cunill et alJ Antoni Ramos-Quiroga, Pedro Lopez-Romero, Chris Bushe
Expert Review of Neurotherapeutics|September 8, 2010
Impulsivity: current and future trends in pharmacological treatmentMaría Dolores Braquehais, J Antoni Ramos-Quiroga, Leo Sher
The Journal of Sexual Medicine|January 28, 2021
The Impact of Psychosis on Sexual Functioning: A Systematic ReviewSebastián Vargas-Cáceres, Nicoletta Cera, Pedro Nobre, et al.
Expert Review of Neurotherapeutics|August 14, 2009
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorderJ Antoni Ramos-Quiroga, Margarida Corominas, Xavier Castells, et al.
European Child & Adolescent Psychiatry|February 15, 2018
Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHDMichael Huss, Bryan Dirks, Joan Gu, et al.
BMC Psychiatry|October 15, 2015
Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in EuropeWalter Deberdt, Johannes Thome, Jeremie Lebrec, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 14, 2017
Time and psychostimulants: Opposing long-term structural effects in the adult ADHD brain. A longitudinal MR studyClara Pretus, J Antoni Ramos-Quiroga, Vanessa Richarte, et al.
Biological Psychiatry|January 22, 2008
A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorderRossella Medori, J Antoni Ramos-Quiroga, Miguel Casas, et al.
Pageof 6